Breast Implants by GC Aesthetics®
GCA® has collaborated with the medical community to develop new and exciting high-quality implants that meet both the surgeon's and patient's needs with proven safety profile based on excellent clinical data for capsular contracture, rupture and BIA-ALCL¹.
GCA® Breast Implants
Surgical Devices
Meet HydroCone™
Use Hydrocone™ with all GCA® implants to minimize post-operative complications¹.
Discover more10-Years of Proven Safety
When it comes to safety, not all breast implants are created equal. GCA® breast implants have 10-year safety data that provides evidence to support the safety, efficacy and performance. 1.500 patients evaluated for 10 years in the largest european multi-centric prospective study.
GCA®
ParagelTM (ES)*
Competitor 1
Competitor 2
Competitor 3
Competitor 4 / Competitor 5 / Competitor 6
GCA Comfort Plus™ Warranty
All GCA® Breast Implants are covered by the GCA Comfort Plus™ Warranty.
GCA Comfort Plus™ Warranty
A comprehensive free lifetime warranty² for your patients. GC Aesthetics® is so confident and proud of the proven quality and long-term safety⁵ of our products that we back them with one of the most comprehensive warranty on the market which includes:
The lifetime replacement of implants in case of rupture and capsular contracture².
Reoperation reimbursement in the rare event of BIA-ALCL and free of charge implant replacement².
No time limitation, it is available for the lifetime of the patient².
Important information
This form is for reporting complaints, product quality issues, or suspected adverse events relating to GC Aesthetics Products. Completing this form does not replace your legal rights or obligation to report a suspected incident directly to your healthcare provider. If you or the patient is experiencing a medical emergency or requires urgent medical attention, please contact emergency services or your treating clinician immediately rather than using this form.
Information you provide will be used by GC Aesthetics to investigate the complaint and, where required, to assess and fulfil its post-market surveillance and vigilance reporting obligations under applicable medical device legislation (including, as relevant, Regulation (EU) 2017/745 and the UK Medical Devices Regulations 2002, as amended). This may involve sharing relevant details with regulators, notified bodies, or competent authorities, as legally required. Please ensure the information provided is accurate and complete to the best of your knowledge. Submission of this form does not constitute an admission of liability or fault by GC Aesthetics, and GC Aesthetics' investigation of a complaint does not guarantee any particular outcome, remedy, or compensation.
Personal data submitted through this form will be processed in accordance with GC Aesthetics' Privacy Notice, available below https://www.gcaesthetics.com/patient-privacy-notice. GC Aesthetics aims to acknowledge receipt of complaints within 21 business days, though investigation timeframes will vary depending on complexity.
*Study conducted with GCA® breast implants: Round Collection™ and The Matrix™.
*GC Aesthetics®: Implant rupture was diagnosed by surgeon examination only (Not MRI cohort).
Not head to head studies. Based on comparison of key complications.
*The third party trademarks used herein are trademarks of respective owners.
1. Data on file, GC Aesthetics®, 2021.
2. Data on file, GC Aesthetics®, 2020.